This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, B.
Right arrow Articles by Lamb, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, B.
Right arrow Articles by Lamb, R. A.

 Previous Article  |  Next Article 

Journal of Virology, May 2001, p. 4068-4079, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4068-4079.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

The SH Integral Membrane Protein of the Paramyxovirus Simian Virus 5 Is Required To Block Apoptosis in MDBK Cells

Biao He,1 Grace Y. Lin,2 Joan E. Durbin,3 Russell K. Durbin,3 and Robert A. Lamb1,2,*

Howard Hughes Medical Institute1 and Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208-3500,2 and Children's Research Institute, Children's Hospital, and Division of Pathology, Department of Pediatrics, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio 432053

Received 7 November 2000/Accepted 5 February 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In some cell types the paramyxovirus simian virus 5 (SV5) causes little cytopathic effect (CPE) and infection continues productively for long periods of time; e.g., SV5 can be produced from MDBK cells for up to 40 days with little CPE. SV5 differs from most paramyxoviruses in that it encodes a small (44-amino-acid) hydrophobic integral membrane protein (SH). When MDBK cells were infected with a recombinant SV5 containing a deletion of the SH gene (rSV5Delta SH), the MDBK cells exhibited an increase in CPE compared to cells infected with wild-type SV5 (recovered from cDNA; rSV5). The increased CPE correlated with an increase in apoptosis in rSV5Delta SH-infected cells over mock-infected and rSV5-infected cells when assayed for annexin V binding, DNA content (propidium iodide staining), and DNA fragmentation (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling assay). In rSV5Delta SH-infected MDBK cells an increase in caspase-2 and caspase-3 activities was observed. By using peptide inhibitors of individual caspases it was found that caspase-2 and caspase-3 were activated separately in rSV5Delta SH-infected cells. Expression of caspase-2 and -3 in rSV5Delta SH-infected MDBK cells appeared not to require STAT1 protein, as STAT1 protein could not be detected in SV5-infected MDBK cells. When mutant mice homologous for a targeted disruption of STAT1 were used as a model animal system and infected with the viruses it was found that rSV5Delta SH caused less mortality than wild-type rSV5, consistent with the notion of clearance of apoptotic cells in a host species.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Apoptosis, or programmed cell death, is the physiological process by which unwanted cells undergo morphologic changes, protease activation, chromosomal DNA fragmentation, and eventually cell death. This process is important for normal development, tissue homeostasis, immune modulation, and host defense against viral infection (reviewed in reference 13). The caspases (cysteine aspartate-specific proteases) play important roles in regulating different apoptotic pathways (39). Caspases can be roughly divided into initiator and effector caspases. Initiator caspases are involved in upstream regulatory events, and effector caspases are directly responsible for proteolytic cleavages that lead to cell death. Known initiator caspases include caspase-8 and -9, and known effector caspases include caspase-3, -6, and -7. Some caspases, such as caspase-2, can be both initiator and effector caspases. Viral infections can activate a variety of cellular pathways that lead to apoptosis. For example, interferons produced in response to viral infections activate pathways leading to activation of caspase-1, -3, and -8 and subsequent apoptosis (6, 36). Among the negative-stranded enveloped RNA viruses, influenza virus, vesicular stomatitis virus, rabies virus, Sendai virus, and Newcastle disease virus (NDV) are known to induce apoptosis in tissue culture cells (reviewed in reference 33). In a natural infection, the infected host organisms are thought to inhibit and eliminate viral infection by sacrificing virus-infected cells through apoptosis. However, many viruses have also developed means to delay and inhibit apoptosis to avoid being eliminated along with their host cells. For example, cowpox virus encodes a viral protein, CrmA, that blocks apoptosis by inhibiting caspase-1 and caspase-3 (37, 42), and Epstein-Barr virus, adenovirus, and herpes simplex virus express multiple viral proteins that inhibit apoptosis at different steps of apoptotic cascades (15, 33).

Simian virus 5 (SV5) is a member of the Rubulavirus genus of the family Paramyxoviridae, a genus which includes many important human and animal pathogens, such as mumps virus, human parainfluenza virus types 2 and 4 and NDV. Although SV5 was originally isolated from cultured primary monkey cells, its natural host is the dog, in which it causes kennel cough (26). Other members of the Paramyxoviridae include Sendai virus, human parainfluenza virus type 3, measles virus, canine distemper virus, rinderpest virus, and respiratory syncytial (RS) virus. SV5 contains a negative-sense single-stranded RNA of 15,246 nucleotides and encodes eight known viral proteins: nucleocapsid protein (N), V protein, phosphoprotein (P), matrix protein (M), fusion protein (F), small hydrophobic integral membrane protein (SH), hemagglutinin-neuraminidase (HN), and polymerase protein (L). The P protein mRNA is synthesized through a cotranscriptional RNA editing process in which two nontemplated G residues are inserted into the templated mRNA transcript (38). The N, P, V, and L proteins are associated with the RNA genome to form the nucleocapsid core; minimally, N, P, and L form the viral transcription and replication complex. The SV5 V protein appears to be a multifunctional protein, as it is also involved in regulating the SV5-induced interferon response. It has been found that the V protein mediates the degradation of signal transducer and activation of transcription (STAT1) (9), a transcription factor required for the interferon response (7). The V protein also interacts with the cellular protein DDB1 (24), and this interaction may be involved in the known effect of V protein slowing the progression of the cell cycle in virus-infected cells (23). The M protein is a peripheral membrane protein, and the SH, F, and HN proteins are integral membrane proteins. F and HN are involved in viral entry into cells, and HN is important for virus release from cells (reviewed in reference 22).

The SV5 SH integral membrane protein is a minor component of virions (17). The SH protein contains 44 amino acid residues with a predicted C-terminal ectodomain of 5 residues, a transmembrane domain of 23 residues, and an N-terminal cytoplasmic tail of 16 residues. By using reverse genetic procedures for SV5 (18), it was found that an SH-deletion-containing SV5 (rSV5Delta SH) could be recovered, indicating that the SH protein was not essential for virus viability in tissue culture. The growth rates, infectivities, and plaque sizes of wild-type SV5 recovered from cDNA (rSV5) and rSV5Delta SH were found to be very similar. In addition, in a quantitative assay for the ability of rSV5 and rSV5Delta SH to cause cell-cell fusion, no difference was observed (17).

The SH gene is not common to all members of the Paramyxoviridae, and the only other virus that contains an analogous gene located between the genes for F and HN is the closely related Rubulavirus, mumps virus (11, 34). In the Pneumovirus RS virus, a gene encoding a third integral membrane protein, designated SH, has been identified (5, 28). However, the RS virus SH protein is considerably larger than that of SV5, and it is not known if the RS virus SH protein is a functional counterpart of the SV5 SH protein. A recombinant RS virus with the SH gene deleted is also viable in tissue culture (3).

A defining characteristic of SV5 is that the virus can grow in MDBK cells for up to 40 days with little observable cytopathic effect (CPE) (4). We report here that MDBK cells infected with rSV5Delta SH exhibit extensive CPE in contrast to wild-type rSV5-infected MDBK cells and this CPE is due to induction of caspase-dependent apoptosis.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Viruses and cells. HeLa T4, A549, L929, MDBK, and MDCK cells were maintained in Dulbecco modified Eagle medium (DMEM) with 10% fetal calf serum (FCS). BHK 21-F cells were maintained in DMEM with 10% tryptose phosphate broth and 10% FCS. Cell lines previously contaminated with mycoplasma were cured using ciprofloxacin (10 µg/ml) (Bayer AG, West Haven, Conn.). All cells used were determined to be free of mycoplasma contamination by using a PCR-based assay and specific DNA primers (Boehringer-Mannheim, Indianapolis, Ind.).

rSV5Delta SH was generated by using a reverse genetics method from an infectious clone of SV5 (plasmid pBH 276) (18) from which the SH gene was deleted (plasmid pBH324) (17). rSV5 and rSV5Delta SH were grown in MDBK cells and harvested 5 to 7 days postinfection (p.i.) as described previously (29). Virus stocks were mycoplasma free. Virus titers were determined by plaque assay using BHK 21-F cells (30). For virus infection, cell monolayers were washed with phosphate-buffered saline (PBS) and then infected with viruses in DMEM-1% bovine serum albumin (BSA) at a multiplicity of infection (MOI) of 0. 1 to 10 PFU/cell for 1 to 2 h at 37°C. The monolayers were then washed and incubated with DMEM containing 2% FCS at 37°C.

Apoptosis assays: annexin V binding, propidium iodide staining of DNA, and TUNEL assay. Confluent MDBK cells in 6-cm plates were infected with SV5 at an MOI of 10 PFU/cell. One or three days p.i. the monolayers were trypsinized and combined with the floating cells in the media. The harvested cells were then pelleted by centrifugation at 250 × g for 10 min at 4°C and washed with PBS. For annexin V binding, the cells were incubated with fluorescein isothiocyanate (FITC)-labeled annexin (annexin-V-FLUOS) for 15 min at room temperature according to the manufacturer's protocol (Roche Diagnostics Corp, Mannheim, Germany). The fluorescence of 20,000 cells was examined by using a FACSCalibur flow cytometer (Becton Dickinson Immunocytometry Systems, San Jose, Calif.). For propidium iodide staining, infected cells were harvested as described above and then fixed with 0.25% formaldehyde for 2 h at 4°C and washed in PBS. The fixed cells were resuspended in 1 ml 50%-DMEM-50% FCS, permeabilized by adding 3 ml of 70% ethanol, and incubated at 4°C for at least 2 h and up to 3 days. The permeabilized cells were incubated with monoclonal antibody (MAb) P-k (specific for V and P proteins) (32) (0.5 ml of a 1:500 dilution in PBS-1% BSA) at 4°C for 1 h, washed extensively with PBS, and then incubated with FITC-labeled anti-mouse secondary antibody (Organon-Teknika Corp., Charlotte, N.C.) (0.5 ml at 1:1,000 in PBS-1% BSA) for 1 h at 4°C. The cells were finally incubated with 500 µl of 50-µg/ml propidium iodide (Sigma-Aldrich, St. Louis, Mo.) for 1 h at 4°C. The cells were then analyzed on a FACSCalibur flow cytometer. Infected cells were selected by plotting FL2-A (DNA content) versus FL1-H (V and P expression).

For terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assays, the cells were harvested and permeabilized as described above for propidium iodide staining. The cells were then incubated with 50 µl of TUNEL reaction mixture (in situ cell death detection kit; Roche Diagnostics Corp.) for 2 to 3 h in the dark at 37°C. Phycoerythrin-labeled secondary antibody was used, and the cells were analyzed by flow cytometry. For TUNEL assays of nuclei, the cells were incubated with 500 µl of hypotonic buffer (20 mM Tris-Cl [pH 7.8], 5 mM MgCl2, 0.2 mM EDTA, 1 mM dithiothreitol, 5 mM beta -glycerolphosphate, 0.5 mM phenylmethylsulfonyl fluoride, and 10 µg of pepstatin, aprotinin, and leupeptin/ml) on ice for 15 min to release nuclei. The nuclei were pelleted by centrifugation at 1,000 rpm for 10 min using a tabletop centrifuge and resuspended in PBS. The nuclei were then incubated with 50 µl of TUNEL reaction mixture containing FITC-labeled dUTP for 2 to 3 h at 37°C. The fluorescence intensity of the nuclei was analyzed by flow cytometry. For in situ TUNEL assays, cells grown on coverslips were fixed with 0.5% formaldehyde for 1 h and then permeabilized with 50% ethanol-50% PBS with 1% BSA for 1 h at 4°C. The cells were first incubated with MAb P-k and then with Texas red-labeled secondary antibody. Subsequently, the cells were incubated with 50 µl of TUNEL reagent for 2 h at 37°C in a humidified incubator. The cells were examined using an LSM 410 confocal microscope (Zeiss Inc., Thornwood, N.Y.). To quantify in situ TUNEL assay fluorescence, 10 random fields were chosen and numbers of fluorescent nuclei were counted.

Single-step growth rate. Monolayers of HeLa T4 and MDBK cells in 35-mm plates were washed with PBS and then infected with rSV5 or rSV5Delta SH in DMEM-1% BSA at an MOI of 10 PFU/cell for 1 to 2 h at 37°C. The cells were then washed with PBS and maintained in DMEM-2% FCS. Viruses released into media were collected at 0, 6, 12, 18, 36, 72, and 144 h p.i. The titers of viruses were determined by plaque assay on BHK 21F cells.

Caspase activity assay. Assay kits for assaying caspase activity were purchased from Chemicon International, Inc. (Temecula, Calif.). Assays were carried out using the manufacturer's protocol, and released chromophore was quantified using a microplate reader with a 405-nm filter (Bio-Tek Instruments, Inc. Winooski, Vt.).

Inhibition of apoptosis with caspase inhibitors. All caspase inhibitors were purchased from Enzyme Systems (Livermore, Calif.) and dissolved in dimethyl sulfoxide. After infection of MDBK cells with rSV5 and rSVDelta SH, the cells were maintained in DMEM-2% FCS containing the caspase inhibitors. Peptide caspase inhibitors were dissolved in dimethyl sulfoxide; the general caspase inhibitor Z-VAD-FMK was used at a final concentration of 200 µM, the caspase-2 inhibitor Z-VAVAD-FMK was used at 50 µM, and the caspase-3 inhibitor Z-DEVD-FMK was used at 100 µM.

Immunoblotting. MDBK cells in 6-cm plates were infected with rSV5Delta SH or rSV5, and 2 and 4 days p.i., cells were lysed in 0.5 ml of protein lysis buffer (2% sodium dodecyl sulfate [SDS], 62.5 mM Tris-HCl [pH 6.8], 2% dithiothreitol) and lysates were sonicated briefly to shear DNA. Lysate (80 µl) was subjected to SDS-polyacrylamide gel electrophoresis using a 10% gel (30). Polypeptides were transferred to Immobilon-P membrane (Millipore Corp., Bedford, Mass.) using a wet-gel transfer apparatus (Bio-Rad, Hercules, Calif.). The membrane was incubated first with primary antibodies against STAT1 (a mixture of A-2, C-136, and E-23; Santa Cruz Biotechnology, Inc., Santa Cruz, Calif.) and then with a mixture of anti-mouse and anti-rabbit immunoglobulin secondary antibodies conjugated to horseradish peroxidase. The proteins on the membrane were detected using the ECL+ kit (Amersham Pharmacia, Piscataway, N.J.), and chemiluminescence was detected using a Storm System PhosphorImager (Molecular Dynamics Inc., Sunnyvale, Calif.).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

rSV5Delta SH causes CPE in MDBK cells. SV5 replicates in MDBK cells for many days with minimal CPE (4) (Fig. 1A). In contrast, on careful examination of MDBK cells infected with rSV5Delta SH (a recombinant SV5 that lacks the SH gene), it was observed that by 4 days p.i. there was extensive cell loss from the monolayers and by 15 days p.i. the monolayers were lost completely (Fig. 1A). However, when MDBK cells were coinfected with rSV5Delta SH and wild-type rSV5 at equal multiplicities, the CPE was not observed (Fig. 1B). Furthermore, when wild-type rSV5 was used to superinfect rSV5Delta SH-infected MDBK cells, 24 h after the first infection, CPE was inhibited (data not shown). These data suggest that expression of the SH protein confers an effect that prevents CPE in MDBK cells.


View larger version (125K):
[in this window]
[in a new window]
  		FIG. 1.   Infection of MDBK cells with rSV5Delta SH induces a CPE that is overcome by coinfection with rSV5. (A) MDBK cells in 12-well plates were infected with rSV5 or rSV5Delta SH at an MOI of 10 PFU/cell. At 4 and 15 days p.i. the cells were stained using HEMA3 and photographed at a magnification of ×200. (B) MDBK cells in six-well plates were infected with rSV5 or rSV5Delta SH, or coinfected with both viruses. At 4 days p.i. the cells were stained and photographed.

rSV5Delta SH induces apoptosis in MDBK cells. To investigate whether the observed CPE in rSV5Delta SH-infected MDBK cells was due to apoptosis, we used three different measurements of apoptosis that when taken together are strong indicators of apoptosis: (i) increase in annexin V binding due to loss of asymmetry in cell membrane phospholipids, (ii) DNA content decrease, measured using propidium iodine staining, and (iii) increase in DNA fragmentation, assayed using the TUNEL assay.

Apoptotic cells undergo a loss of asymmetry in cell membrane phospholipids with an increase of phosphatidyl serine on the outer leaflet. Annexin V, a calcium-dependent phospholipid-binding protein, has a high affinity for phosphatidyl serine, and it can be used to monitor changes in phosphatidyl serine localization. When mock-infected, rSV5-infected, or rSV5Delta SH-infected MDCK cells at 3 days p.i. were incubated with FITC-labeled annexin V and the fluorescent cells were examined by flow cytometry, a considerable increase in annexin V binding was observed in rSV5Delta SH-infected cells (binding level [mean ± standard error of the mean] of 38.88% ± 0.46%) compared to mock-infected (10.66% ± 0.25%) or rSV5-infected (13.58% ± 1.02%) cells.

For propidium iodide staining, MDBK cells were mock infected, rSV5 infected, or rSV5Delta SH infected, and at 1 or 3 days p.i., the cells (floating and attached) were harvested, permeabilized, and incubated with propidium iodide. Analysis of the cells by flow cytometry showed that at 1 day p.i. in either rSV5- or rSV5Delta SH-infected cells very few cells had reduced DNA staining below that of G0-G1 (sub-G0-G1) cells, the usual criterion for apoptotic cells (27). However, by 3 days p.i. about 40% of rSV5Delta SH-infected MDBK cells had a sub-G0-G1 DNA staining level, compared to 13% for rSV5-infected cells and 4% for mock-infected cells (Fig. 2). To check viral expression levels in rSV5- and rSV5Delta SH-infected cells, cells were also stained with MAb P-k (32), which is specific for the P and V proteins. Fluorescence was measured by flow cytometry, and the P and V expression levels in rSV5- and rSV5Delta SH-infected cells were found to be equivalent (data not shown). To confirm that the rSV5Delta SH-infected MDBK cells undergo a greater extent of apoptosis than rSV5-infected MDBK cells, the extent of DNA fragmentation was examined by an in situ fluorescent TUNEL assay, and at 1 day and 3 days p.i. cells were analyzed by flow cytometry. As shown in Fig. 3, by 3 days p.i. ~35% of rSV5Delta SH-infected MDBK cells were apoptotic whereas only a small fraction of rSV5-infected or mock-infected MDBK cells were apoptotic.


View larger version (35K):
[in this window]
[in a new window]
  		FIG. 2.   Detection of DNA content of rSV5- and rSV5Delta SH-infected MDBK cells using propidium iodide staining. MDBK cells in 6-cm plates were infected and processed for propidium iodide staining of DNA 1 or 3 days p.i. as described in Materials and Methods. (A) DNA staining of 10,000 cells was detected by flow cytometry. "FL2-A" indicates DNA content; "A" indicates sub-G0-G1 DNA content, which is considered apoptotic. (B) Histogram of data computed from three samples like those shown in panel A for each time point and virus.


View larger version (36K):
[in this window]
[in a new window]
  		FIG. 3.   TUNEL assay of rSV5- and rSV5Delta SH-infected MDBK cells. MDBK cells were mock infected or infected with rSV5 or rSV5Delta SH and at 1 or 3 days p.i. were processed for the TUNEL assay as described in Materials and Methods. (A) Detection by flow cytometry of fluorescently labeled DNA. The area marked "Apoptotic" indicates fluorescence intensity of cells considered positive for the TUNEL assay and hence apoptotic. (B) Histogram of three independent experiments as in panel A at each time point.

To determine if rSV5Delta SH caused CPE and apoptosis in cell lines other than MDBK (bovine) cells, L929 (mouse) cells, MDCK (canine) cells, HeLa T4 (human) cells, and A549 (human) cells were infected with rSV5 and rSV5Delta SH and examined for CPE at various times p.i. The cell types infected with rSV5 did not show evidence of severe CPE (Fig. 4). However, for rSV5Delta SH-infected cells, severe CPE was observed in L929 cells 2 to 3 days p.i. and in MDCK cells at 6 to 7 days p.i. In contrast, rSV5Delta SH-infected HeLa T4 cells and A549 cells showed little CPE even after 7 days p.i. (Fig. 4). The extent of apoptosis was then quantified by using a TUNEL assay, and as shown in Table 1, the CPE observed in rSV5Delta SH-infected L929 and MDCK cells correlated with induction of apoptosis. None of the infected cell types showed evidence of large syncytia, although rSV5-infected HeLa cells did show an occasional multinucleated cell. CV-1 (monkey) and BHK (hamster) cells were not used in this study of rSV5Delta SH-induced apoptosis because on SV5 infection they exhibit extensive syncytium formation.


View larger version (151K):
[in this window]
[in a new window]
  		FIG. 4.   CPE in human, canine, and mouse cells infected with rSV5Delta SH. A549, HeLa T4, MDCK, and L929 cells were infected at an MOI of 10 PFU per cell. At various times cells were stained with HEMA3. A549 cells and HeLa T4 cells were stained 7 days p.i., MDCK cells were stained 6 days p.i., and L929 cells were stained 3 days p.i.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   Induction of apoptosis by rSV5Delta SH infectiona 

Apoptosis does not confer a growth advantage in tissue culture cells. It is usually thought that programmed cell death of virus-infected cells is beneficial for the host organism, as death of infected cells provide a means of inhibiting or eliminating virus spread. However, some viruses take advantage of apoptosis as a means of releasing or spreading virions more efficiently. For example, human immunodeficiency virus is reported to have an increased release of virions from apoptotic cells (1). To determine if apoptosis induced in rSV5Delta SH-infected cells facilitated virus growth, the single-step rates of growth of rSV5 and rSV5Delta SH were determined in MDBK and HeLa T4 cells. As shown in Fig. 5, the growth curves of rSV5 and rSV5Delta SH in MDBK cells were similar, as were the growth curves in HeLa T4 cells.


View larger version (17K):
[in this window]
[in a new window]
  		FIG. 5.   Single-step growth rate of rSV5Delta SH, compared to rSV5, is not affected by apoptosis. Confluent MDBK (A) or HeLa (B) cells in 35-mm plates were infected with rSV5 or rSV5Delta SH at an MOI of 10 PFU per cell. Media were collected 0, 6, 12, 18, 36, 72, and 144 h p.i. The viral titers were determined by plaque assay using BHK 21F cells.

rSV5Delta SH-induced apoptosis in MDBK cells involves the caspase pathway. Although there are a variety of pathways leading to apoptosis, the majority, but not all, of these pathways culminate in the activation of caspases, the major effectors of programmed cell death. To investigate the role of caspases in rSV5Delta SH-induced apoptosis, a general caspase peptide inhibitor, Z-VAD-FMK, was used. As shown in Fig. 6A, addition of Z-VAD-FMK to rSV5Delta SH-infected MDBK cells largely prevented the CPE observed in mock-treated cells. An in situ TUNEL assay was performed on cells grown on coverslips, and it was found that addition of Z-VAD-FMK to rSV5Delta SH-infected MDBK cells reduced the number of apoptotic cells (Fig. 6B). To quantify the TUNEL assay, Z-VAD-FMK-treated or mock-treated cells (attached cells and released cells in supernatant) were harvested, nuclei were prepared and subjected to a TUNEL assay protocol, and fluorescence was analyzed by flow cytometry. As shown in Fig. 6C, Z-VAD-FMK treatment reduced the number of rSV5Delta SH-infected MDBK cells from ~15% to 2%. Importantly for the interpretation of these experiments, Z-VAD-FMK did not affect the accumulation of SV5-specific protein in cells, as determined by immunoblotting of treated and mock-treated infected-cell lysates (data not shown).


View larger version (54K):
[in this window]
[in a new window]
  		FIG. 6.   Apoptosis in rSV5Delta SH-infected MDBK cells is inhibited by a general caspase inhibitor, Z-VAD-FMK. MDBK cells were infected with rSV5Delta SH and treated with Z-VAD-FMK (200 µM) for 3 days. (A) Cells were stained with HEMA3 and photographed. (B) In situ TUNEL assay showing FITC staining. All FITC-stained cells were infected with SV5, as shown by Texas red staining for the P- and V-specific MAb. (C) Quantification of TUNEL assay. The cells were harvested and treated with hypotonic buffer to release nuclei. The nuclei were treated with TUNEL assay reagent and analyzed by flow cytometry. The averages of three separate experiments are shown.

rSV5Delta SH-induced apoptosis in MDBK cells involves caspase-2 and caspase-3. The caspases are synthesized as inactive procaspase precursors that are converted to the active form by proteolytic cleavage, catalyzed by other caspases. Regulation of caspase activation is thus critical to cell survival. To investigate which caspases are activated in rSV5Delta SH-infected MDBK cells at 3 days p.i., cell lysates were prepared and assayed for specific caspases using a colorimetric assay (see Materials and Methods). As shown in Fig. 7A, caspase-2 and caspase-3 activities were increased in rSV5Delta SH-infected MDBK cells compared to those in mock-infected cells. It was also observed that caspase-2 and caspase-3 activities were increased in rSV5-infected cells compared to those in mock-infected cells but not to the extent observed in rSV5Delta SH-infected cells. In contrast to the increased activities of caspase-2 and caspase-3, the activities of caspase-1, caspase-8, and caspase-9 were only very slightly increased in rSV5Delta SH-infected MDBK cells compared to activities in mock-infected cells.


View larger version (27K):
[in this window]
[in a new window]
  		FIG. 7.   Caspase activities of rSV5Delta SH- and SV5-infected MDBK cells. (A) Activities of caspase-1, -2, -3, -8, and -9. MDBK cells were infected with rSV5Delta SH or rSV5, and 3 days p.i. the cells were lysed. Caspase activities of cytosolic extracts were measured as described in Materials and Methods. (B) Inhibition of apoptosis by caspase-2 and caspase-3 inhibitors. MDBK cells on coverslips were infected with rSV5Delta SH in the presence of caspase inhibitors (Z-VAVAD-FMK, 50 µM; Z-DEVD-FMK, 100 µM) and processed for the TUNEL assay as described in Materials and Methods. Fluorescence was visualized using a Zeiss LSM 410 confocal microscope. Average numbers of apoptotic nuclei from 10 randomly chosen fields are shown.

To determine whether the increases in caspase-2 and caspase-3 activity found in rSV5Delta SH-infected MDBK cells are important for rSV5Delta SH-mediated apoptosis, rSV5Delta SH-infected MDBK cells on coverslips were treated with the specific caspase-2 inhibitor Z-VAVAD-FMK and/or the specific caspase-3 inhibitor Z-DEVD-FMK, and an in situ TUNEL assay was performed. As shown in Fig. 7B, it was found that the individual caspase-2 and caspase-3 inhibitors partially blocked apoptosis in rSV5Delta SH-infected MDBK cells, but when added in combination, they largely inhibited apoptosis. Thus, the data suggest that both caspase-2- and caspase-3-like activities contribute independently to apoptosis in rSV5Delta SH-infected MDBK cells.

STAT1 is not required for activation of caspase-2 and caspase-3. Interferons are produced in response to many viral infections. Interferons activate, through receptor-mediated signal transduction and activation of the transcription factor STAT1, pathways leading to activation of caspase-1, -3, and -8 and subsequent apoptosis (6, 36). Thus, it was important to know whether the apoptosis induced in rSV5Delta SH-infected MDCK cells was due to an altered STAT1 response. In human 2fTGH cells infected with SV5, the viral V protein mediates the degradation of STAT1, hence ablating interferon signaling (9). However, in mouse cells infected with SV5, STAT1 is not degraded and the viral infection is limited by the interferon response (8). As shown above, infection of mouse L929 cells with rSV5Delta SH caused severe CPE and apoptosis whereas CPE was not observed in rSV5Delta SH-infected cells of human origin (HeLa T4 and A549 cells). To examine the status of STAT1 in rSV5- and rSV5Delta SH-infected MDBK cells, lysates were prepared at 2 and 4 days p.i. and subjected to Western blotting using antibodies against STAT1 protein. As shown in Fig. 8, STAT1alpha and -beta were detected in mock-infected MDBK cells but not in rSV5- or rSV5Delta SH-infected cells. Thus, these data suggest that in rSV5Delta SH-infected MDBK cells, as in human 2fTGH cells, STAT1 is absent and that expression of caspase-2 and caspase-3 does not depend on STAT1 protein and pathways associated with STAT1.


View larger version (26K):
[in this window]
[in a new window]
  		FIG. 8.   Activation of caspase-2 and -3 does not require STAT1. MDBK cells infected with rSV5Delta SH or rSV5 were lysed 2 and 4 days p.i. Lysates were subjected to SDS-polyacrylamide gel electrophoresis on 10% gels and immunoblotted using antibodies specific for STAT1.

rSV5Delta SH is less pathogenic in STAT1-/- mice than wild-type rSV5. To examine the pathogenicity of rSV5Delta SH in vivo, a small animal model system is needed. However, SV5 infection of laboratory strains of inbred mice does not cause morbidity or mortality. Recently, we established a small animal model system for studying SV5 pathogenesis using BALB/c mutant mice homozygous for a targeted disruption of STAT1. The STAT1-/- BALB/c mice are the ninth backcross generation of 129 × C57BL/6 STAT1-/- mice (10) to BALB/c. A full description of this model system will be published elsewhere. Mice were inoculated intranasally with rSV5Delta SH or rSV5. As shown in Table 2, all the mice survived infection by rSV5Delta SH at a dosage of 105 PFU and five out of six mice survived infection by rSV5Delta SH at a dosage of 106 PFU. In contrast, wild-type rSV5 infection of STAT1-/- mice resulted in significant mortality (six out of six died after infection with 106 PFU, and three out of six died after infection with 105 PFU). To show that the viruses replicated in the mouse lung, at 4 days p.i. two groups of three mice inoculated with 106 PFU virus were sacrificed and lungs were homogenized. rSV5Delta SH and rSV5 were found to grow to average titers of 9.5 × 105 and 5.8 × 106 PFU/g of lung tissue, respectively. These data suggest that rSV5Delta SH is less pathogenic in vivo than wild-type rSV5, even though it causes vastly greater CPE in mouse, bovine, and canine cell types, a finding consistent with the notion of clearance of apoptotic cells in a host species.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Survival of STAT1-/- mice following SV5 infectiona


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Many members of the Paramyxoviridae have been found to cause severe CPE and apoptosis. Sendai virus causes apoptosis by activating caspase-3 and caspase-8 (2, 16, 19). Measles virus not only induces apoptosis in the cells it infects (12) but also induces apoptosis of uninfected activated T lymphocytes, possibly by producing functional TRAIL from measles virus-infected dendritic cells (14, 40). NDV causes apoptosis by eliciting interferon- and tumor necrosis factor-mediated responses (25, 43). RS virus is thought to enhance neutrophil apoptosis in vivo (41), but it does not cause apoptosis in tissue-cultured cells, even though RS virus infection results in severe CPE (35). In contrast, SV5 multiplies for long periods with minimal CPE in many cell types (4).

Initial examination of a recombinant SV5 lacking its SH gene indicated that the recovered rSV5Delta SH virus was indistinguishable from rSV5 in terms of growth rate, plaque size, virus yield, and fusion activity (17). Further investigation of properties of rSV5Delta SH indicated that it was able to induce severe CPE and apoptosis in L929, MDCK, and MDBK cells but little detectable CPE and apoptosis in A549 and HeLa T4 cells (Fig. 4 and Table 1). As coinfection of rSV5Delta SH with rSV5 did not result in CPE, this observation lends support to the notion that expression of the SH protein is the key factor in preventing induction of apoptosis. The time required for CPE to be observed was also different in different cell lines. Mouse L929 cells took the least time (2 to 3 days) to exhibit massive CPE, while MDCK cells took 5 to 7 days p.i. The observation that rSV5Delta SH can grow efficiently in HeLa T4 cells without causing severe CPE (Fig. 5) indicates that there may be another viral protein(s) that prevents CPE and apoptosis in HeLa cells. It has been reported that the deletion of the V gene from Sendai virus resulted in a virus that causes more CPE in some but not all cell lines (20). The SV5 V protein has been found to bind to zinc, associate with the cellular protein DDB1, cause a delay in progression through the cell cycle, and cause degradation of STAT1 protein in human cells but not mouse cells (9, 23, 24, 31). Whether the V protein of SV5 is involved in blocking CPE and/or apoptosis in the human cells is not clear. We are currently attempting to generate a SV5 without the V gene to explore the possibility that V may be involved in blocking apoptosis in HeLa T4 and A549 cells. Although rSV5Delta SH causes vastly greater CPE in mouse, bovine, and canine cell types than wild-type rSV5, it was found that rSV5Delta SH was less pathogenic than wild-type rSV5 in STAT1-/- mice, the only available small animal model for studying the pathogenesis of SV5. This finding is consistent with the notion of clearance of apoptotic cells in a host species.

To investigate the cellular processes utilized to cause apoptosis in the absence of expression of the SH protein, a general caspase inhibitor, Z-VAD-FMK, was used, and it was found to block apoptosis in rSV5Delta SH-infected MDBK cells. The observed increased activities of caspase-2 and caspase-3 in rSV5Delta SH-infected MDBK cells suggest that SH is required to block upstream signaling of caspase-2 and caspase-3 activation. We do not know whether the moderate increase of caspase-3 activity in SV5-infected MDBK cells is significant (Fig. 6A), but wild-type-rSV5-infected cells also had a slightly higher number of apoptotic cells than mock-infected cells (Fig. 3B). Thus, SV5 infection of MDBK cells may not result in a complete inhibition of apoptosis.

The pathway by which apoptosis occurs in rSV5Delta SH-infected cells together with the mechanism by which SH protein interferes with the apoptotic pathway remains to be determined. It seems likely that the SH cytoplasmic tail interacts with cellular proteins that are involved in apoptotic signaling, and this also remains to be determined. The data indicate that caspase-2 and caspase-3, but not caspase-1, -8, and -9, are activated in rSV5Delta SH-infected MDBK cells, suggesting that the latter caspases are not activators of caspase-2 and -3 in the rSV5Delta SH-infected cells. The fact that the inhibitor of caspase-2 did not block apoptosis completely suggests that activation of caspase-3 does not depend on caspase-2. Previously, it has been found that STAT1 protein is required for expression of caspase-2 and caspase-3 (21). However, STAT1 protein was not detected in rSV5Delta SH-infected MDBK cells, possibly because STAT1 protein underwent SV5 V protein-mediated degradation, as occurs in SV5-infected human cells (9). Thus, it is unlikely that activation of caspase-2 and caspase-3 in rSV5Delta SH-infected MDBK cells depends on STAT1 protein or interferon responses.


    ACKNOWLEDGMENTS

We thank Anthony P. Schmitt and Reay G. Paterson and many other members of the Lamb lab for helpful discussions.

This research was supported in part by Public Health Service Research Award AI-23173 from the National Institute of Allergy and Infectious Diseases. G.Y.L. was supported by NIH Medical Scientist Training Program grant T32 GM-08152. B.H. is an Associate and R.A.L. is an Investigator of the Howard Hughes Medical Institute.


    FOOTNOTES

* Corresponding author. Dept. of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, 2153 North Campus Dr., Evanston, IL 60208-3500. Phone: (847) 491-5433. Fax: (847) 491-2467. E-mail: ralamb{at}northwestern.edu.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Antoni, B. A., P. Sabbatini, A. B. Rabson, and E. White. 1995. Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J. Virol. 69:2384-2392[Abstract].
2. Bitzer, M., F. Prinz, M. Bauer, M. Spiegel, W. J. Neubert, M. Gregor, K. Schulze-Osthoff, and U. Lauer. 1999. Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). J. Virol. 73:702-708[Abstract/Free Full Text].
3. Bukreyev, A., S. S. Whitehead, B. R. Murphy, and P. L. Collins. 1997. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71:8973-8982[Abstract].
4. Choppin, P. W. 1964. Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference. Virology 23:224-233[CrossRef][Medline].
5. Collins, P. L., and G. W. Wertz. 1985. Nucleotide sequences of the 1B and 1C nonstructural protein mRNAs of human respiratory syncytial virus. Virology 143:442-451[CrossRef][Medline].
6. Dai, C., and S. B. Krantz. 1999. Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93:3309-3316[Abstract/Free Full Text].
7. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630-1635[Abstract/Free Full Text].
8. Didcock, L., D. F. Young, S. Goodbourn, and R. E. Randall. 1999. Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J. Virol. 73:3125-3133[Abstract/Free Full Text].
9. Didcock, L., D. F. Young, S. Goodbourn, and R. E. Randall. 1999. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:9928-9933[Abstract/Free Full Text].
10. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450[CrossRef][Medline].
11. Elango, N., J. Kovamees, T. M. Varsanyi, and E. Norrby. 1989. mRNA sequence and deduced amino acid sequence of the mumps virus small hydrophobic protein gene. J. Virol. 63:1413-1415[Abstract/Free Full Text].
12. Esolen, L. M., S. W. Park, J. M. Hardwick, and D. E. Griffin. 1995. Apoptosis as a cause of death in measles virus-infected cells. J. Virol. 69:3955-3958[Abstract].
13. Evan, G., and T. Littlewood. 1998. A matter of life and cell death. Science 281:1317-1322[Abstract/Free Full Text].
14. Fugier-Vivier, I., C. Servet-Delprat, P. Rivailler, M. C. Rissoan, Y. J. Liu, and C. Rabourdin-Combe. 1997. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:813-823[Abstract/Free Full Text].
15. Galvan, V., and B. Roizman. 1998. Herpes simplex virus 1 induces and blocks apoptosis at multiple steps during infection and protects cells from exogenous inducers in a cell-type-dependent manner. Proc. Natl. Acad. Sci. USA 95:3931-3936[Abstract/Free Full Text].
16. Garcin, D., G. Taylor, K. Tanebayashi, R. Compans, and D. Kolakofsky. 1998. The short Sendai virus leader region controls induction of programmed cell death. Virology 243:340-353[CrossRef][Medline].
17. He, B., G. P. Leser, R. G. Paterson, and R. A. Lamb. 1998. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology 250:30-40[CrossRef][Medline].
18. He, B., R. G. Paterson, C. D. Ward, and R. A. Lamb. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237:249-260[CrossRef][Medline].
19. Itoh, M., H. Hotta, and M. Homma. 1998. Increased induction of apoptosis by a Sendai virus mutant is associated with attenuation of mouse pathogenicity. J. Virol. 72:2927-2934[Abstract/Free Full Text].
20. Kato, A., K. Kiyotani, Y. Sakai, T. Yoshida, and Y. Nagai. 1997. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J. 16:578-587[CrossRef][Medline].
21. Kumar, A., M. Commane, T. W. Flickinger, C. M. Horvath, and G. R. Stark. 1997. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278:1630-1632[Abstract/Free Full Text].
22. Lamb, R. A., and D. Kolakofsky. 1996. Paramyxoviridae: the viruses and their replication, p. 1177-1204. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
23. Lin, G. Y., and R. A. Lamb. 2000. The V protein of the paramyxovirus simian parainfluenza virus 5 (SV5) slows progression of the cell cycle. J. Virol. 74:9152-9166[Abstract/Free Full Text].
24. Lin, G. Y., R. G. Paterson, C. D. Richardson, and R. A. Lamb. 1998. The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology 249:189-200[CrossRef][Medline].
25. Lorence, R. M., P. A. Rood, and K. W. Kelley. 1988. Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity. J. Natl. Cancer Inst. 80:1305-1312[Abstract/Free Full Text].
26. McCandlish, I. A., H. Thompson, H. J. Cornwell, and N. G. Wright. 1978. A study of dogs with kennel cough. Vet. Rec. 102:293-301[Abstract].
27. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271-279[CrossRef][Medline].
28. Olmsted, R. A., and P. L. Collins. 1989. The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species. J. Virol. 63:2019-2029[Abstract/Free Full Text].
29. Paterson, R. G., T. J. R. Harris, and R. A. Lamb. 1984. Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology 138:310-323[CrossRef][Medline].
30. Paterson, R. G., and R. A. Lamb. 1993. The molecular biology of influenza viruses and paramyxoviruses, p. 35-73. In A. Davidson, and R. M. Elliott (ed.), Molecular virology: a practical approach. IRL Oxford University Press, Oxford, United Kingdom.
31. Paterson, R. G., G. P. Leser, M. A. Shaughnessy, and R. A. Lamb. 1995. The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology 208:121-131[CrossRef][Medline].
32. Randall, R. E., D. F. Young, K. K. A. Goswami, and W. C. Russell. 1987. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68:2769-2780[Abstract/Free Full Text].
33. Roulston, A., R. C. Marcellus, and P. E. Branton. 1999. Viruses and apoptosis. Annu. Rev. Microbiol. 53:577-628[CrossRef][Medline].
34. Takeuchi, K., K. Tanabayashi, M. Hishiyama, and A. Yamada. 1996. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 225:156-162[CrossRef][Medline].
35. Takeuchi, R., H. Tsutsumi, M. Osaki, K. Haseyama, N. Mizue, and S. Chiba. 1998. Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta -converting enzyme gene expression but does not cause apoptosis. J. Virol. 72:4498-4502[Abstract/Free Full Text].
36. Tanaka, N., M. Sato, M. S. Lamphier, H. Nozawa, E. Oda, S. Noguchi, R. D. Schreiber, Y. Tsujimoto, and T. Taniguchi. 1998. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3:29-37[Abstract].
37. Tewari, M., W. G. Telford, R. A. Miller, and V. M. Dixit. 1995. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J. Biol. Chem. 270:22705-22708[Abstract/Free Full Text].
38. Thomas, S. M., R. A. Lamb, and R. G. Paterson. 1988. Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell 54:891-902[CrossRef][Medline].
39. Thornberry, N. A., and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312-1316[Abstract/Free Full Text].
40. Vidalain, P. O., O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-Combe, and C. Servet-Delprat. 2000. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74:556-559[Abstract/Free Full Text].
41. Wang, S. Z., P. K. Smith, M. Lovejoy, J. J. Bowden, J. H. Alpers, and K. D. Forsyth. 1998. The apoptosis of neutrophils is accelerated in respiratory syncytial virus (RSV)-induced bronchiolitis. Clin. Exp. Immunol. 114:49-54[CrossRef][Medline].
42. Zhou, Q., S. Snipas, K. Orth, M. Muzio, V. M. Dixit, and G. S. Salvesen. 1997. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272:7797-8800[Abstract/Free Full Text].
43. Zorn, U., I. Dallmann, J. Grosse, H. Kirchner, H. Poliwoda, and J. Atzpodien. 1994. Induction of cytokines and cytotoxicity against tumor cells by Newcastle disease virus. Cancer Biother. 9:225-235[Medline].

Journal of Virology, May 2001, p. 4068-4079, Vol. 75, No. 9
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.9.4068-4079.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Talbert-Slagle, K., Marlatt, S., Barrera, F. N., Khurana, E., Oates, J., Gerstein, M., Engelman, D. M., Dixon, A. M., DiMaio, D. (2009). Artificial Transmembrane Oncoproteins Smaller than the Bovine Papillomavirus E5 Protein Redefine Sequence Requirements for Activation of the Platelet-Derived Growth Factor {beta} Receptor. J. Virol. 83: 9773-9785 [Abstract] [Full Text]  
  • Randall, R. E., Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47 [Abstract] [Full Text]  
  • Dillon, P. J., Parks, G. D. (2007). Role for the Phosphoprotein P Subunit of the Paramyxovirus Polymerase in Limiting Induction of Host Cell Antiviral Responses. J. Virol. 81: 11116-11127 [Abstract] [Full Text]  
  • Fuentes, S., Tran, K. C., Luthra, P., Teng, M. N., He, B. (2007). Function of the Respiratory Syncytial Virus Small Hydrophobic Protein. J. Virol. 81: 8361-8366 [Abstract] [Full Text]  
  • Martin, G., Cagnon, N., Sabido, O., Sion, B., Grizard, G., Durand, P., Levy, R. (2007). Kinetics of occurrence of some features of apoptosis during the cryopreservation process of bovine spermatozoa. Hum Reprod 22: 380-388 [Abstract] [Full Text]  
  • Dillon, P. J., Wansley, E. K., Young, V. A., Alexander-Miller, M. A., Parks, G. D. (2006). Exchange of P/V genes between two non-cytopathic simian virus 5 variants results in a recombinant virus that kills cells through death pathways that are sensitive to caspase inhibitors. J. Gen. Virol. 87: 3643-3648 [Abstract] [Full Text]  
  • Wilson, R. L., Fuentes, S. M., Wang, P., Taddeo, E. C., Klatt, A., Henderson, A. J., He, B. (2006). Function of Small Hydrophobic Proteins of Paramyxovirus. J. Virol. 80: 1700-1709 [Abstract] [Full Text]  
  • Jack, P. J. M., Boyle, D. B., Eaton, B. T., Wang, L.-F. (2005). The Complete Genome Sequence of J Virus Reveals a Unique Genome Structure in the Family Paramyxoviridae. J. Virol. 79: 10690-10700 [Abstract] [Full Text]  
  • Takeuchi, K., Takeda, M., Miyajima, N., Ami, Y., Nagata, N., Suzaki, Y., Shahnewaz, J., Kadota, S.-i., Nagata, K. (2005). Stringent Requirement for the C Protein of Wild-Type Measles Virus for Growth both In Vitro and in Macaques. J. Virol. 79: 7838-7844 [Abstract] [Full Text]  
  • Springfeld, C., Darai, G., Cattaneo, R. (2005). Characterization of the Tupaia Rhabdovirus Genome Reveals a Long Open Reading Frame Overlapping with P and a Novel Gene Encoding a Small Hydrophobic Protein. J. Virol. 79: 6781-6790 [Abstract] [Full Text]  
  • Chatziandreou, N., Stock, N., Young, D., Andrejeva, J., Hagmaier, K., McGeoch, D. J., Randall, R. E. (2004). Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J. Gen. Virol. 85: 3007-3016 [Abstract] [Full Text]  
  • Sun, M., Rothermel, T. A., Shuman, L., Aligo, J. A., Xu, S., Lin, Y., Lamb, R. A., He, B. (2004). Conserved Cysteine-Rich Domain of Paramyxovirus Simian Virus 5 V Protein Plays an Important Role in Blocking Apoptosis. J. Virol. 78: 5068-5078 [Abstract] [Full Text]  
  • Al-Molawi, N., Beardmore, V. A., Carter, M. J., Kass, G. E. N., Roberts, L. O. (2003). Caspase-mediated cleavage of the feline calicivirus capsid protein. J. Gen. Virol. 84: 1237-1244 [Abstract] [Full Text]  
  • Henrickson, K. J. (2003). Parainfluenza Viruses. Clin. Microbiol. Rev. 16: 242-264 [Abstract] [Full Text]  
  • Lin, Y., Bright, A. C., Rothermel, T. A., He, B. (2003). Induction of Apoptosis by Paramyxovirus Simian Virus 5 Lacking a Small Hydrophobic Gene. J. Virol. 77: 3371-3383 [Abstract] [Full Text]  
  • Neumann, G., Whitt, M. A., Kawaoka, Y. (2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol. 83: 2635-2662 [Abstract] [Full Text]  
  • Wansley, E. K., Parks, G. D. (2002). Naturally Occurring Substitutions in the P/V Gene Convert the Noncytopathic Paramyxovirus Simian Virus 5 into a Virus That Induces Alpha/Beta Interferon Synthesis and Cell Death. J. Virol. 76: 10109-10121 [Abstract] [Full Text]  
  • Waning, D. L., Schmitt, A. P., Leser, G. P., Lamb, R. A. (2002). Roles for the Cytoplasmic Tails of the Fusion and Hemagglutinin-Neuraminidase Proteins in Budding of the Paramyxovirus Simian Virus 5. J. Virol. 76: 9284-9297 [Abstract] [Full Text]  
  • Teng, M. N., Collins, P. L. (2002). The Central Conserved Cystine Noose of the Attachment G Protein of Human Respiratory Syncytial Virus Is Not Required for Efficient Viral Infection In Vitro or In Vivo. J. Virol. 76: 6164-6171 [Abstract] [Full Text]  
  • Schmitt, A. P., Leser, G. P., Waning, D. L., Lamb, R. A. (2002). Requirements for Budding of Paramyxovirus Simian Virus 5 Virus-Like Particles. J. Virol. 76: 3952-3964 [Abstract] [Full Text]  
  • Zhirnov, O. P., Konakova, T. E., Wolff, T., Klenk, H.-D. (2002). NS1 Protein of Influenza A Virus Down-Regulates Apoptosis. J. Virol. 76: 1617-1625 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, B.
Right arrow Articles by Lamb, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, B.
Right arrow Articles by Lamb, R. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»